Cyclic Nitroxide 4-Methoxy-Tempo May Decrease Serum Amyloid A-Mediated Renal Fibrosis and Reorganise Collagen...

Area of Science:

• Biomedical Science
• Cardiovascular Research
• Renal Physiology

Background:

• Serum amyloid A (SAA) is an acute-phase protein linked to vascular dysfunction, diabetes, cardiovascular disease, and rheumatoid arthritis.
• Cyclic nitroxides, such as Tempo, are known to inhibit oxidative stress and inflammation.
• The potential of 4-methoxy-Tempo (4-MetT) to counteract SAA-induced pathologies requires investigation.

Purpose of the Study:

• To investigate whether 4-methoxy-Tempo (4-MetT) can inhibit vascular and renal dysfunction induced by SAA.
• To explore the effects of 4-MetT on SAA-mediated changes in vascular function, nitric oxide signaling, and inflammatory pathways.
• To assess the impact of 4-MetT on SAA-induced renal inflammation, fibrosis, and atherosclerotic lesion development in ApoE-deficient mice.

Main Methods:

• In vitro assessment of 4-MetT's effect on SAA-impaired vascular relaxation and cyclic guanosine monophosphate (cGMP) levels.
• In vivo study using ApoE-deficient mice administered SAA ± 4-MetT (prophylactically or therapeutically).
• Analysis of renal and cardiac tissues for inflammation (IFN-γ, iNOS, p38MAPK), fibrosis (Picrosirius red), and aortic root lesion size at 4 and 16 weeks.

Main Results:

• SAA reduced acetylcholine-mediated vascular relaxation and aortic cGMP levels; 4-MetT dose-dependently restored these parameters.
• SAA administration increased renal inflammation and fibrosis, associated with upregulated IFN-γ, iNOS, p38MAPK, and MMP activities.
• SAA significantly enhanced aortic root lesion size; 4-MetT supplementation did not significantly alter renal dysfunction or lesion size but reduced renal fibrosis and altered aortic lesion collagen distribution.

Conclusions:

• SAA promotes renal dysfunction via the IFN-γ-iNOS-p38MAPK pathway, leading to renal damage and accelerated atherosclerosis.
• 4-methoxy-Tempo (4-MetT) demonstrated partial protective effects against SAA-induced pathological changes, particularly in mitigating renal fibrosis and altering aortic lesion composition.
• These findings suggest that while 4-MetT may offer some benefit, its impact on SAA-mediated vascular and renal dysfunction is complex and warrants further investigation.